Oncology Monitor Expands in Pacific

Synovate Healthcare has announced the extension of its Tandem Global Oncology Monitor into China, Korea and Australia. The Monitor is already established in Japan.

The service, described as the largest therapy monitor in the industry, covers key pharmaceutical markets across Europe, the US and Asia.

Synovate says the move is a response to a clear client need for consistent data from key markets around the world. Yee-Shuan Shen, Head of the Asia Pacific Tandem Oncology Monitor, comments: 'Oncology is an increasing focus for our AP clients and they really have embraced the
monitor's unique benefits and insight gained through the established monitors in the US,
Europe and Japan.'

According to Jackie Ilacqua, Executive Director of the Global Tandem Oncology Monitor, the company expects to continue the expansion into other countries of interest to clients, and has 'exciting plans for expanding our oncology portfolio overall.'

The division's home page is at www.synovate.com/healthcare .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• All news